Identification of CREB5 as a prognostic and immunotherapeutic biomarker in glioma through multi-omics pan-cancer analysis

被引:1
作者
Wu Z. [1 ,2 ,3 ]
Wang X. [2 ]
Wu H. [1 ]
Du S. [4 ]
Wang Z. [4 ]
Xie S. [1 ]
Zhang R. [4 ]
Chen G. [3 ]
Chen H. [1 ]
机构
[1] Department of Oncology, The First Affiliated Hospital of Wenzhou Medical University, Zhejiang, Wenzhou
[2] Department of Burns and Skin Repair Surgery, The Third Affiliated Hospital of Wenzhou Medical University, Zhejiang, Ruian
[3] The Quzhou Affiliated Hospital of Wenzhou Medical University, Quzhou People's Hospital, Zhejiang, Quzhou
[4] Department of Pathology, The First Affiliated Hospital of Wenzhou Medical University, Zhejiang, Wenzhou
基金
俄罗斯科学基金会;
关键词
Cyclic adenosine monophosphate response element binding protein 5; Glioma; Multi-omics; Pan-cancer; Tumor microenvironment;
D O I
10.1016/j.compbiomed.2024.108307
中图分类号
学科分类号
摘要
Background: The functional relevance of cyclic adenosine monophosphate (cAMP)-response element-binding protein 5 (CREB5) in cancers remains elusive, despite its significance as a member of the CREB family. The current research aims to explore the role of CREB5 in multiple cancers. Methods: Pan-cancer analysis was performed to explore the expression patterns, prognostic value, mutational landscape as well as single-cell omic, immunologic, and drug sensitivity profiles of CREB5. Furthermore, we incorporated five distinct machine learning algorithms and determined that the least absolute shrinkage and selection operator-COX (LASSO-COX) algorithm, which exhibited the highest C index, was the optimal selection. Subsequently, we constructed a prognostic model centered around CREB5-associated genes. To elucidate the biological function of CREB5 in glioma cells, several assays including cell counting kit-8 (CCK-8), wound healing, transwell, flow cytometric were performed. Results: CREB5 was overexpressed in pan-cancer and was linked to unfavorable prognosis, particularly in glioma. Furthermore, genetic alterations were determined in various types of cancer, and modifications in the CREB5 gene were linked to the prognosis. The single-cell omics and enrichment analyses showed that CREB5 was predominantly expressed in malignant glioma cells and was critically involved in the regulation of various oncogenic processes. Elevated levels of CREB5 were strongly linked with the infiltration of cancer-associated fibroblasts and the Th1 subset of CD4+ T cells. The validated CREB5-associated prognostic model reliably predicted the prognosis and drug response of glioma patients. The in vitro experiments showed that CREB5 promoted glioma cell proliferation, invasion, migration, and gap phase 2/mitotic (G2/M) phase arrest and recruited M2 macrophages into glioma cells. Conclusion: CREB5 has the potential to act as an oncogene and a biological marker in multiple cancers, particularly glioma. © 2024
引用
收藏
相关论文
共 54 条
[1]  
Schumacher M.A., Goodman R.H., Brennan R.G., The structure of a CREB bZIP.somatostatin CRE complex reveals the basis for selective dimerization and divalent cation-enhanced DNA binding, J. Biol. Chem., 275, 45, pp. 35242-35247, (2000)
[2]  
Sapio L., Salzillo A., Ragone A., Illiano M., Spina A., Naviglio S., Targeting CREB in cancer therapy: a Key candidate or one of many? An update, Cancers, 12, 11, (2020)
[3]  
Impey S., McCorkle S.R., Cha-Molstad H., Dwyer J.M., Yochum G.S., Boss J.M., McWeeney S., Dunn J.J., Mandel G., Goodman R.H., Defining the CREB regulon: a genome-wide analysis of transcription factor regulatory regions, Cell, 119, 7, pp. 1041-1054, (2004)
[4]  
Belgacem Y.H., Borodinsky L.N., CREB at the crossroads of activity-dependent regulation of nervous system development and function, Adv. Exp. Med. Biol., 1015, pp. 19-39, (2017)
[5]  
Pigazzi M., Ricotti E., Germano G., Faggian D., Arico M., Basso G., cAMP response element binding protein (CREB) overexpression CREB has been described as critical for leukemia progression, Haematologica, 92, 10, pp. 1435-1437, (2007)
[6]  
Steven A., Friedrich M., Jank P., Heimer N., Budczies J., Denkert C., Seliger B., What turns CREB on? And off? And why does it matter?, Cell. Mol. Life Sci., 77, 20, pp. 4049-4067, (2020)
[7]  
Nomura N., Zu Y.L., Maekawa T., Tabata S., Akiyama T., Ishii S., Isolation and characterization of a novel member of the gene family encoding the cAMP response element-binding protein CRE-BP1, J. Biol. Chem., 268, 6, pp. 4259-4266, (1993)
[8]  
Zu Y.L., Maekawa T., Nomura N., Nakata T., Ishii S., Regulation of trans-activating capacity of CRE-BPa by phorbol ester tumor promoter TPA, Oncogene, 8, 10, pp. 2749-2758, (1993)
[9]  
Smith C.L., Blake J.A., Kadin J.A., Richardson J.E., Bult C.J., Mouse Genome Database (MGD)-2018: knowledgebase for the laboratory mouse, Nucleic Acids Res., 46, D1, pp. D836-d842, (2018)
[10]  
Zhang C.H., Gao Y., Hung H.H., Zhuo Z., Grodzinsky A.J., Lassar A.B., Creb5 coordinates synovial joint formation with the genesis of articular cartilage, Nat. Commun., 13, 1, (2022)